Risk Factors and HDL
To the Editor:
The recent paper by Castelli et al. confirms certain previously suspected epidemiologic inverse correlations between HDL levels and coronary artery disease. 1 The continuous brilliant work performed by the Framingham Group represents an invaluable contribution to both clinical investigators and the practicing physician. However, a word of caution should be stated against broad generalizations in such a complex field as is the one of human atherosclerosis. This specifically pertains to the practical use of the HDL-coronary artery disease risk relationship. Figure 1 of the paper is quite contradictory when one compares the moderate and high HDL patients at higher levels of LDL.
Some private laboratories are already reporting coronary artery disease risk based on HDL numbers, and many practicing physicians are going through a stage of confusion and uncertainty as to what action to take with a particular individual who may or may not have coronary artery disease. This is even more relevant with the asymptomatic group. To establish a definite risk for coronary artery disease based just on an HDL number is premature and possibly detrimental. On first view, it would appear that other risk factors are of lesser importance and not as significant. In my own clinical experience measuring complete lipoprotein profiles in patients with suspected or proven coronary artery disease, I have found many cases that can illustrate some of the possible contradictions involved. For example, Patient R.S., age 64, female, chronic stable angina pectoris with two vessel obstructive disease proven by angiography, had HDL levels of 70; Patient T.F., 54-year-old female with chronic established angina and proven myocardial infarction, had HDL level of 120; Patient H.K., 50-year-old diabetic, insulin dependent, three vessel disease proven by angiography, status post double aortocoronary bypass for refractory angina, HDL level 68. According to the recently published statistics, none of these patients will be considered a significant risk for coronary dis- The author replies.
To the Editor: Dr. Rotsztain is, of course, right: It is important to put the HDL-CHD findings in perspective.
Risk variables are just thatthey only tell you what the chances are of a class of persons developingthe specified disease. Some highrisk persons will not develop the disease and some low risk persons will.
Furthermore, estimates of CHD risk should not be made on the basis of a single characteristic, HDL cholesterol or any other. CHD is a multifactorial disease and is poorly predicted by any single risk factor, so far as we know.
With respect to HDL cholesterol an additional caution may be made: A high level may betoken low risk but it may represent some potentially pathologic perturbation. For example, people on estrogens tend to have elevations of HDL cholesterol but estrogens appear to raise CHD risk. And, of course, a low level may betoken a laboratory error -a serious problem with this measurement. Here, as elsewhere, a modicum of care in clinical evaluation and a touch of intellectual modesty doesn't hurt.
The Having read with great interest the "Critical review of the systolic time intervals" by Lewis et al. (Circulation 56: 146, 1977) , it seems that a few points need reconsideration and discussion.
The suggestion that the systolic time intervals be expressed in practice as "systolic time interval indices" is both conceptually misleading and factually erroneous. As the authors themselves state the indices are values of the intercepts of the regression equations and therefore hypothetical figures. Clearly there can be no LVET or QS2 at a heart rate of zero which is what the indices imply! On this count alone the use of such indices should be vigorously discouraged.
Apart from the conceptual illusion there is a further factual error. The standard deviations quoted for the intercept values (the STI indices) are in fact the standard deviations (SD) 
Clearly the variances of the regression coefficient (b) and the intercept (a) cannot be transposed. Furthermore the confidence intervals of a regression function are generally curvilinear bending away from the mean toward either end and therefore widest apart at the intercept (a). Obviously reference to the true confidence intervals of the intercept would tend to increase the chances of false negative values of significance. For comparisons of individual population figures only the wider population variances should be used rather than the confidence intervals of the regression lines. However, when fitted regression analyses of individual patient data are available, it is perfectly justifiable to use the narrower confidence intervals of the regression lines. For the present there appears no escape from the tedium of having to work out the deviations from the predicted value at a given cycle length from the entire regression equation and relating it to the population confidence intervals at that value on the abscissa. However, at slight expense of accuracy the busy clinician could use a nomogram of the type shown in figure 1 . The predicted value (and its 2 X SD) at a given RR interval can be quickly read off and compared with the values in a patient.
The systolic time intervals are generally measured from a few recorded cardiac pulses, usually ten. The laborious process of converting the RR cycle intervals into a computed heart rate (HR) seems unnecessary. The STI show a linear relation, both with the RR cycle length and the HR; the only difference is that the signs are different, positive in the former case and negative in the latter. The fact that the frequency dependence of STI is linear for both HR and RR intervals is not necessarily surprising and readily explained on the basis of the statistics of the data. It seems much more logical therefore to use regressions of STI upon RR intervals in preference to the current recommendations.2 The significance of this suggestion becomes particularly apparent when one is dealing with patients with sinus arrhythmia or the like. Corrections applicable to each cycle length successfully overcome the apparent difficulties. The author replies: To the Editor: I thank Dr. Sapru for his comments on our recent article. I must, however, respectfully disagree with all three of his suggestions.
The use of systolic time interval index values is well established and of proven usefulness. Conceptually it does not differ from other index values used in cardiology (which also do not, in fact, exist) such as cardiac index, stroke index, etc.
The standard deviation quoted for our regression equations is the standard deviation of the residuals, not the standard deviation of the regression coefficients. We have used 95% confidence intervals based upon the standard deviation of the residuals to define the normal interval for our population.1 Of note, the 95% confidence intervals are nearly straight lines. This is a result of population homogeneity and large sample size. Hence, use of the standard deviation of the residuals which represents the mean deviation from the regression line for the population is acceptable in this setting. Since we are already using population variances, I would assume Dr. Sapru would have no quarrel with our approach.
Dr. Sapru stated that the STI show a linear relation with both the RR cycle length and the heart rate. This is simply not true. Figure 
